Releaf in the Press: Highlights from the Medical Cannabis Sector 2024
2 min read
Lucy MacKinnon
Contents
Releaf has been at the forefront of the UK medical cannabis sector throughout 2024, garnering widespread media attention for its innovative patient-first approach and groundbreaking initiatives. From leading the conversation around accessibility to driving awareness of medical cannabis treatment options, Releaf has consistently made headlines, shaping the narrative of this rapidly evolving industry. With notable features in national publications and influential platforms, the spotlight on Releaf reflects its commitment to transforming lives and redefining the future of medical cannabis care in the UK.
The Times: June 2024
"Legal cannabis by post: inside the farm behind a British first"
Yahoo! News: November 2024
"Mum praises ‘miracle’ cannabis vape for ‘saving my son’ after mainstream treatments failed"
The Business Desk: October 2024
"Historic medical cannabis deal set to create jobs for Nottingham firm"
Manchester Evening News: November 2024
"Man fit the criteria for a 'cannabis card' after a quick Google"
MSN News: November 2024
"I'm a social worker and I use cannabis daily for health reasons' says 47-year-old Milton Keynes woman"
The Mirror: October 2024
"My son was wasting away, cannabis came to his rescue when doctors couldn’t"
The Daily Start: December 2024
"Releaf medical cannabis helped me reduce my pain and anxiety"
BBC Radio Cambridgeshire: December 2024
Share article
Did you like this article?
It is important to seek medical advice before starting any new treatments. The patient advisors at Releaf are available to provide expert advice and support. Alternatively, click here to book a consultation with one of our specialist doctors.
Elevate your wellness with medical cannabis
Get comprehensive care, convenience, and confidence with an all-in-one treatment plan.
Am I eligible?Authors
With five years of journalism and healthcare content creation under her belt, Lucy strives to improve medical cannabis awareness and access in the UK by producing high quality, credible content.
Editorial Policy
All of our articles are written by medical cannabis experts, guided by strict sourcing guidelines, and reference peer-reviewed studies and credible academic research. Our expert clinical team and compliance specialists provide valuable insights to ensure accuracy when required. Learn more in our editorial policy.
Need more help?
Blog Categories
Further reading
Decoding Cannabis: what a recent scoping review reveals about cannabis for rheumatoid arthritis
A recent scoping review has dug into how cannabinoids interact with inflammation, joint tissue, and pain signalling in rheumatoid arthritis. This article breaks down what the researchers found, how THC and CBD influence key inflammatory pathways, and what these insights may mean for people living with arthritis in the UK. We also look at how this evidence compares with current patient experiences.
Why fewer than 1% of UK doctors are trained in medical cannabis and how Releaf is working to change it
Reports suggest that fewer than 1% of eligible UK specialists are trained to prescribe medical cannabis. This gap leaves many patients without informed support. This outline explains why the gap exists and how Releaf’s clinicians follow a structured, evidence-based training pathway that leads the industry. It also highlights Releaf’s wider educational work, including police workshops that improve understanding of legal patient access.
Travel Tuesday: Travelling to Greece with medical cannabis
Every year, millions of people flock to Greece. With approximately 200 flights travelling from the UK to Greece every week, planning a trip is often a walk in the park. But if you’re travelling to Greece with [medical cannabis](http://releaf.co.uk), things can get a bit more complicated. So, let’s break down all you need to know.